Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 4 Nasopharyngeal Carcinoma 3 Adenocarcinoma Of Esophagus 3 Precancerous Conditions 2 Neoplasms 2 Colorectal Neoplasms 2 Barrett Esophagus 2 Thyroid Neoplasms 1 Signs and Symptoms 1 Rectal Neoplasms 1 Peptic Ulcer 1 Pathologic Complete Response 1 Melanoma 1 Intestinal Neoplasms 1 Inflammatory Bowel Diseases 1 Gastroparesis 1 Gastroesophageal Reflux 1 Gastric Outlet Obstruction 1 Fistula 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Achalasia 1 Colonic Neoplasms 1 Celiac Disease 1 Anemia, Iron-Deficiency 1

Interventions

Nivolumab 25 pembrolizumab 20 Ipilimumab 15 toripalimab 12 Temozolomide 11 Biopsy 8 Dacarbazine 7 Cyclophosphamide 6 Blood Specimen Collection 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 durvalumab 4 binimetinib 4 aldesleukin 4 Interleukin-2 4 Injections 4 Carboplatin 4 tislelizumab 3 palbociclib 3 encorafenib 3 apatinib 3 Sorafenib 3 Paclitaxel 3 Introns 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Endoscopy × Clear all

NCT04879654 2024-03-05

SNMM

Eye & ENT Hospital of Fudan University

Phase 2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡